This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BASF (BASFY) to Expand Basoflux Production Capacity in Tarragona
by Zacks Equity Research
BASF (BASFY) is expanding its Tarragona site to increase the production of innovative and sustainable Basoflux paraffin inhibitors.
Is DRDGOLD Limited (DRD) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how DRDGOLD (DRD) and Ecolab (ECL) have performed compared to their sector so far this year.
Here's What Makes Reliance (RS) Stock a Solid Choice Right Now
by Zacks Equity Research
Reliance (RS) gains on strong underlying demand in its major markets and strategic acquisitions.
Cabot (CBT) Launches Universal Circular Black Masterbatches
by Zacks Equity Research
Cabot (CBT) is well-positioned to create a more sustainable future with its new universal circular black masterbatch solutions made from mechanically recovered polymers.
Is Invesco Water Resources ETF (PHO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PHO
Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication
by Zacks Equity Research
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
by Zacks Equity Research
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
by Zacks Equity Research
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
FMC Corp (FMC) Teams Up With AgroSpheres for Bioinsecticides
by Zacks Equity Research
FMC partners with AgroSpheres to accelerate the development of innovative bioinsecticides, enhancing sustainable crop protection and reinforcing FMC's industry leadership.
Air Products (APD) Unveils PRISM LNG Membrane Separator
by Zacks Equity Research
Air Products' (APD) Membrane Solutions specializes in hollow fiber membrane separators and onsite gas generation.
DuPont (DD) to Showcase Advanced Circuit Materials in Shanghai
by Zacks Equity Research
The new technology solutions highlight DuPont's (DD) capacity to generate innovation and provide value in collaboration with industry leaders in the Artificial Intelligence field.
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
Three Reasons to Retain Integer Holdings (ITGR) Stock for Now
by Zacks Equity Research
Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
by Zacks Equity Research
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
by Zacks Equity Research
Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.
DuPont (DD) Introduces Tyvek Trifecta Breather Membrane
by Zacks Equity Research
DuPont (DD) Tyvek Trifecta complements the DuPont AirGuard A2 FR AVCL, resulting in a comprehensive A-rated membrane system.
Neogen (NEOG) Faces Macroeconomic Issues, Fierce Competition
by Zacks Equity Research
Neogen (NEOG) faces intense competition from companies ranging from small businesses to divisions of large multinational companies.
PacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up
by Zacks Equity Research
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
LyondellBasell (LYB) Announces Review of European Operations
by Zacks Equity Research
LyondellBasell (LYB) is conducting a strategic review of its European operations, focusing on reinvesting in high-return businesses.
Air Products (APD) AP-DMR LNG Process Passes Performance Test
by Zacks Equity Research
Air Products' (APD) innovative AP-DMR LNG Process was chosen for its high efficiency, dependable operation and small footprint.
QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall
by Zacks Equity Research
QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.
Ashland (ASH) to Divest Nutraceuticals Business to Turnspire
by Zacks Equity Research
Ashland (ASH) is set to sell its nutraceuticals business to Turnspire Capital Partners, with the deal expected to close in third-quarter 2024.
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
OPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.
Should You Invest in the Invesco Water Resources ETF (PHO)?
by Zacks Equity Research
Sector ETF report for PHO
McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.